 |
 |
|
|
|
| PCI-32765 |
 |
| 25kg/叩 |
 |
| PCI-32765 is a high potent irreversible BTK inhibitor with an IC50 of 0.46 nM for the purified Btk.[1]PCI-32765 is highly active and well tolerated in CLL/SLL pts irrespective of high risk genomic abnormalities. Although follow-up is short, the high response rate and very low progression rate suggests that PCI-32765 may be an important new targeted treatment approach for CLL pts. |
 |
| PCI-32765 |
|
|
|
|
|
